Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Double-Blind Phase	STARTED	AZLI-AZLI	136
Double-Blind Phase	STARTED	Placebo-AZLI	138
Double-Blind Phase	Randomized and Treated	AZLI-AZLI	135
Double-Blind Phase	Randomized and Treated	Placebo-AZLI	137
Double-Blind Phase	COMPLETED	AZLI-AZLI	119
Double-Blind Phase	COMPLETED	Placebo-AZLI	123
Double-Blind Phase	NOT COMPLETED	AZLI-AZLI	17
Double-Blind Phase	NOT COMPLETED	Placebo-AZLI	15
Open-Label Phase	STARTED	AZLI-AZLI	112
Open-Label Phase	STARTED	Placebo-AZLI	110
Open-Label Phase	COMPLETED	AZLI-AZLI	102
Open-Label Phase	COMPLETED	Placebo-AZLI	98
Open-Label Phase	NOT COMPLETED	AZLI-AZLI	10
Open-Label Phase	NOT COMPLETED	Placebo-AZLI	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01314716/flow